Search Results1-7 of  7

  • Nishii Kazuya ID: 9000403274184

    Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan (2020 from CiNii)

    Articles in CiNii:1

    • A Long-term Response to Nivolumab in a Case of PD-L1-negative Lung Adenocarcinoma with an EGFR Mutation and Surrounding PD-L1-positive Tumor-associated Macrophages (2020)
  • Nishii Kazuya ID: 9000002652083

    Nagoya University of Commerce and Business Administration, Faculty of Foreign Languages and Asian Studies (2002 from CiNii)

    Articles in CiNii:1

    • Survey of the Significance of the Course : Perception of Japanese Culture and Society (2002)
  • Nishii Kazuya ID: 9000258061881

    Department of General Internal Medicine, Japanese Red Cross Okayama Hospital (2011 from CiNii)

    Articles in CiNii:1

    • FDG-PET/CT is useful in the diagnosis of early phase Takayasu's arteritis : A case report (2011)
  • Nishii Kazuya ID: 9000347544784

    Department of Respiratory and Allergy Medicine, Okayama University Hospital (2017 from CiNii)

    Articles in CiNii:1

    • Segmental Lymph Node Metastasis of Gum Cancer Diagnosed by EBUS-TBNA (2017)
  • Nishii Kazuya ID: 9000402241450

    Department of Respiratory Medicine, Okayama University Hospital, Japan (2019 from CiNii)

    Articles in CiNii:1

    • Rapid and Long-term Response of Pulmonary Pleomorphic Carcinoma to Nivolumab (2019)
  • Nishii Kazuya ID: 9000402435815

    Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences (2019 from CiNii)

    Articles in CiNii:1

    • Tumor microenvironment affecting the effect of immuno-checkpoint inhibitors (2019)
  • Nishii Kazuya ID: 9000404645054

    Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Japan (2019 from CiNii)

    Articles in CiNii:1

    • A Long-term Response to Nivolumab in a Case of PD-L1-negative Lung Adenocarcinoma with an <i>EGFR</i> Mutation and Surrounding PD-L1-positive Tumor-associated Macrophages (2019)
Page Top